UB40 founder pulls out of tour after seizure

UB40 saxophonist Brian Travers will miss the band's upcoming tour, including a date in Preston, after suffering two tumours.
Brian Travers performing with UB40Brian Travers performing with UB40
Brian Travers performing with UB40

The founding member of the band will miss the group's upcoming 40th anniversary tour, including a date at Preston Guild Hall on April 19, after suffering a seizure at home.

Read More
Cowboy roofer fly-tipped asbestos in residential Preston street

The musician said he has lived a life free of regrets, and that the only thing left on his bucket list is returning to playing music.

Brian Travers performing with UB40Brian Travers performing with UB40
Brian Travers performing with UB40
Hide Ad
Hide Ad

He will undergo surgery on the day he was due to begin the tour, and is expected to make a recovery within six months.

"They sound great, but I shall be there in spirit, cheering them on from my convalescence and thinking of all the wonderful people out there who have supported us for the last 40 years, who I am now incredibly proud to count as friends.

"I've had a great life with no regrets and have absolutely nothing to add to a bucket list except getting over this and getting back to the thing I love, playing music to anyone who wants to listen and expressing myself through painting and sculpture.

"It's been a huge privilege and I thank you all for the opportunity to 'live the dream'."

Hide Ad
Hide Ad

Red Red Wine creators UB40 have confirmed that the planned tour will still go ahead in Travers' absence.

A statement from the band said: "We're deeply saddened that Brian, our lifelong friend and founding member of UB40, is unable to join us for our celebratory UK tour.

"We know he will be missed by all but his health and well-being come first, and we are sure our friends and fans will join us in wishing Brian a full and speedy return to health, and return to us."

UB40 will begin their UK tour at Portsmouth's Guildhall on Friday.

Related topics: